Due to the central role of EGFR-mediated signaling in promoting cell survival, proliferation and other key functions, once deregulated it can contribute to the activation of critical oncogenic pathways, ultimately leading to uncontrolled cell proliferation, tumor invasiveness, metastasis, angiogenesis and other malignant phenotypes [4,21,22]. This evidence concerns the gene EGFR and neoplasm.